Market Research Industry Reports

Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2018

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2018

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2018, provides an overview of the Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline landscape.

Oral herpes is an infection of the lips, mouth, or gums due to the herpes simplex virus. Oral herpes is also called herpes labialis. Symptoms include sore throat, fever, swollen glands and painful swallowing. Treatment includes antiviral medications.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Herpes Labialis (Oral Herpes) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Herpes Labialis (Oral Herpes) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 4, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Herpes Labialis (Oral Herpes) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Herpes Labialis (Oral Herpes) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Herpes Labialis (Oral Herpes) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Herpes Labialis (Oral Herpes) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Herpes Labialis (Oral Herpes) (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Herpes Labialis (Oral Herpes) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Introduction 4
Herpes Labialis (Oral Herpes) - Overview 5
Herpes Labialis (Oral Herpes) - Therapeutics Development 6
Herpes Labialis (Oral Herpes) - Therapeutics Assessment 12
Herpes Labialis (Oral Herpes) - Companies Involved in Therapeutics Development 20
Herpes Labialis (Oral Herpes) - Drug Profiles 22
Herpes Labialis (Oral Herpes) - Dormant Projects 34
Herpes Labialis (Oral Herpes) - Discontinued Products 35
Herpes Labialis (Oral Herpes) - Product Development Milestones 36
Appendix 39

List Of Tables

List of Tables
Number of Products under Development for Herpes Labialis (Oral Herpes), H1 2018 7
Number of Products under Development by Companies, H1 2018 9
Number of Products under Development by Universities/Institutes, H1 2018 10
Products under Development by Companies, H1 2018 11
Products under Development by Universities/Institutes, H1 2018 12
Number of Products by Stage and Target, H1 2018 14
Number of Products by Stage and Mechanism of Action, H1 2018 16
Number of Products by Stage and Route of Administration, H1 2018 18
Number of Products by Stage and Molecule Type, H1 2018 20
Herpes Labialis (Oral Herpes) - Pipeline by AiCuris GmbH & Co KG, H1 2018 21
Herpes Labialis (Oral Herpes) - Pipeline by Beech Tree Labs Inc, H1 2018 21
Herpes Labialis (Oral Herpes) - Pipeline by NanoViricides Inc, H1 2018 22
Herpes Labialis (Oral Herpes) - Pipeline by Shulov Innovative Science Ltd, H1 2018 22
Herpes Labialis (Oral Herpes) - Dormant Projects, H1 2018 35
Herpes Labialis (Oral Herpes) - Discontinued Products, H1 2018 36

List Of Figures

List of Figures
Number of Products under Development for Herpes Labialis (Oral Herpes), H1 2018 7
Number of Products under Development by Companies, H1 2018 8
Number of Products by Targets, H1 2018 13
Number of Products by Stage and Targets, H1 2018 13
Number of Products by Mechanism of Actions, H1 2018 15
Number of Products by Stage and Mechanism of Actions, H1 2018 15
Number of Products by Routes of Administration, H1 2018 17
Number of Products by Stage and Routes of Administration, H1 2018 17
Number of Products by Molecule Types, H1 2018 19
Number of Products by Stage and Top 10 Molecule Types, H1 2018 19

Genital Herpes - Pipeline Review, H2 2018

Genital Herpes - Pipeline Review, H2 2018The latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Pipeline Review, H2 2018, provides an overview of the Genital Herpes (Infectious Disease)

USD 2000View Report

2018 Global Herpes Diagnostic Testing Market: US, Europe, Japan--Supplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology

USD 4500View Report

Herpes Labialis - Market Insight, Epidemiology and Market Forecast - 2027

DelveInsights Herpes Labialis - Market Insight, Epidemiology and Market Forecast - 2027 report provides a detailed analysis of the Herpes Labialis epidemiology and market outlook for the 7MM.Markets

USD 6250View Report

Herpes Labialis - Epidemiology Forecast to 2027

DelveInsights Herpes Labialis - Epidemiology Forecast, 2027 report provides a comprehensive analysis of the Herpes Labialis epidemiology, providing the historical and forecasted data for the 7MM

USD 3250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 2000
  • Site Licence    USD 4000
  • Enterprise Wide Licence    USD 6000
$ 2000

Reports Details

Published Date : May 2018
No. of Pages :41
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube